---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011701"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2025-05-20T23:59:59+00:00"
generated_at: "2026-05-20T23:48:00.773218+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Lixte receives conversion notice for 350,000 Series A Preferred shares into 72,917 common shares

## Summary
- Notice received May 16, 2025 for 350,000 Series A Convertible Preferred shares.
- Issued to an investor in 2015 and 2016; converts into 72,917 shares of common stock.
- Conversion dilutes existing common equity by approximately 72,917 shares.

## SEC filing metadata
- accession: 0001641172-25-011701
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2025-05-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000164117225011701/0001641172-25-011701-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000164117225011701/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011701
- JSON: https://secwatch.observer/filing/0001641172-25-011701.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011701.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.